Actively Recruiting
Natural History Study for Patients With Angelman Syndrome
Led by Centre Hospitalier Universitaire de Liege · Updated on 2025-05-20
30
Participants Needed
1
Research Sites
324 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de Liege
Lead Sponsor
C
Centre Hospitalier Régional de la Citadelle
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years. The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.
CONDITIONS
Official Title
Natural History Study for Patients With Angelman Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Genetically confirmed diagnosis of Angelman syndrome
- Age between 0 and 99 years
- Male or female gender
- Participant's caregiver willing to give informed consent or sign a record of consultation for study participation
You will not qualify if you...
- Presence of any other medical condition that could affect the study's results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHR Citadelle Liège
Liège, Liège, Belgium, 4000
Actively Recruiting
Research Team
N
Noor Benmhammed
CONTACT
T
Tamara Dangouloff, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here